Mir Hashim's most recent trade in Rani Therapeutics Holdings Inc - Ordinary Shares Class A was a trade of 325,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 23, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Rani Therapeutics Holdings... | Mir Hashim | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 325,000 | 325,000 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Mir Hashim | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 323,500 | 323,500 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Hashim Mir | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2023 | 171,500 | 171,500 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Hashim Mir | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2023 | 171,500 | 34,300 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Hashim Mir | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2023 | 83,724 | 127,788 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Mir Hashim | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2023 | 83,724 | 83,724 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Mir Hashim | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2023 | 73,150 | 52,250 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Mir Hashim | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2023 | 73,150 | 73,150 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Mir Hashim | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 205,800 | 205,800 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Mir Hashim | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 139,000 | 273,265 | - | 0 | Class A Common Stock | |
Rani Therapeutics Holdings... | Mir Hashim | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.95 per share. | 22 Mar 2023 | 4,201 | 134,265 | - | 6.0 | 24,996 | Class A Common Stock |
Rani Therapeutics Holdings... | Mir Hashim | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.89 per share. | 09 Sep 2022 | 20,334 | 138,466 | - | 9.9 | 201,103 | Class A Common Stock |
Rani Therapeutics Holdings... | Mir Hashim | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 125,400 | 125,400 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Mir Hashim | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 41,200 | 158,800 | - | 0 | Class A Common Stock | |
Rani Therapeutics Holdings... | Mir Hashim | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2021 | 117,600 | 117,600 | - | 0 | Class A Common Stock |